'Aren't the Organs a Silver Lining?'
A Longreads investigation examines how Arizona's fentanyl crisis has created an uneasy dynamic where overdose deaths supply a growing number of transplantable organs, raising ethical questions about whether policymakers see this as a "silver lining" of the addiction epidemic.
Background
- The O'Neill Institute for National and Global Health Law at Georgetown University is a prominent research center focused on health law and policy, including drug policy and organ transplantation ethics.
- This article explores a controversial dynamic in the U.S. opioid crisis: as fentanyl and other drug overdoses surged, so did the supply of viable donor organs — since many overdose victims are young and otherwise healthy. This has created an uncomfortable ethical tension between saving lives via transplants and preventing drug deaths.
- Prior context: U.S. organ transplant policy has long struggled with shortages; drug-overdose donors now account for a significant and growing share of all deceased donors. Critics worry this creates perverse incentives or moral hazard, while transplant advocates argue refusing usable organs would waste life-saving opportunities.
- The piece examines how this "silver lining" framing (often from transplant surgeons or policymakers) collides with grief, addiction stigma, and questions about whether society is investing enough in prevention versus relying on tragic supply.